Brief report: U.S. trends in use of colchicine by cardiologists and other specialties, 2018 to 2024
Authors' conclusion
suggesting limited cardiologist adoption of colchicine for ASCVD prevention despite favorable clinical trial data.
Study context
- Population
- Colchicine prescriptions dispensed through US retail pharmacies (National Prescription Audit), March 2018 to February 2024
- Outcome
- Volume and trends of colchicine prescriptions
- Follow-up
- March 2018 to February 2024
Main finding
As reported in the abstract
Colchicine prescriptions · since 2020
Increase in total monthly prescriptions since 2020, driven primarily by cardiologists
6%
Cardiologists' share of national monthly prescription totals
2.8%-4%
Estimated incremental prescriptions/month by cardiologists since 2020
∼4000
Original publication
Brief report: U.S. trends in use of colchicine by cardiologists and other specialties, 2018 to 2024. Am Heart J. Published 22 October 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →